Table 1.
Clinical and demographic characteristics of study population.
| Total n = 28 |
HYPO n = 18 |
NO-HYPO n = 10 |
p Value HYPO vs. NO-HYPO |
|
|---|---|---|---|---|
| Male gender—n (%) | 5 (17.9) | 3 (16.7) | 2 (20) | 1.000 |
| Age (years) | 41 ± 11 | 40 ± 12 | 41 ± 10 | 0.832 |
| Current BMI (Kg/m2) | 27 ± 4 | 27 ± 4 | 26 ± 3 | 0.296 |
| Preoperative BMI (Kg/m2) | 44 ± 7 | 45 ± 7 | 43 ± 6 | 0.377 |
| TBWL (%) | 39 ± 6 | 39 ± 5 | 39 ± 8 | 0.982 |
| EWL (%) | 79 ± 11 | 78 ± 12 | 83 ± 10 | 0.317 |
| RYGB—n (%) | 12 (42.9) | 9 (50) | 3 (30) | 0.434 |
| Fasting blood glucose (mg/dL) | 74 ± 8 | 73 ± 9 | 75 ± 6 | 0.387 |
| Smoking habit n (%) | 10 (35.7) | 7 (38.9) | 3 (30) | 0.703 |
| Dyslipidemia n—(%) | 2 (7.1) | 0 (0) | 2 (20) | 0.119 |
| Hypertension n—(%) | 4 (14.3) | 1 (5.6) | 3 (30) | 0.116 |
| Obesity n—(%) | 5 (17.9) | 4 (22.2) | 1 (10) | 0.626 |
| ≥1 vascular risk factor—n (%) | 18 (64.3) | 11 (61.1) | 7 (70) | 0.703 |
BMI: body mass index; TBWL: total body weight loss; EWL: excess weight loss; RYGB: Roux-en-Y gastric bypass.